Xeris Biopharma Holdings, Inc. (XERS)

Arcadium Lithium Statistics

Total Valuation

XERS has a market cap or net worth of $1.06 billion. The enterprise value is $1.25 billion.

Market Cap	1.06B
Enterprise Value	1.25B

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

XERS has 160.16 million shares outstanding. The number of shares has increased by 8.03% in one year.

Current Share Class	160.16M
Shares Outstanding	160.16M
Shares Change (YoY)	+8.03%
Shares Change (QoQ)	+4.60%
Owned by Insiders (%)	4.62%
Owned by Institutions (%)	54.72%
Float	152.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	2,200.00
PS Ratio	4.09
Forward PS	3.71
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.10
EV / EBITDA	149.94
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95

Current Ratio	1.95
Quick Ratio	1.18
Debt / Equity	n/a
Debt / EBITDA	16.27
Debt / FCF	n/a
Interest Coverage	-0.12

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-0.70%
Return on Invested Capital (ROIC)	-0.95%
Return on Capital Employed (ROCE)	-1.55%
Revenue Per Employee	$624,429
Profits Per Employee	-$81,216
Employee Count	394
Asset Turnover	0.74
Inventory Turnover	0.79

Taxes

Income Tax	-3.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +192.04% in the last 52 weeks. The beta is 0.86, so XERS's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+192.04%
50-Day Moving Average	4.93
200-Day Moving Average	4.17
Relative Strength Index (RSI)	80.38
Average Volume (20 Days)	2,356,017

Short Selling Information

The latest short interest is 19.55 million, so 12.21% of the outstanding shares have been sold short.

Short Interest	19.55M
Short Previous Month	19.97M
Short % of Shares Out	12.21%
Short % of Float	12.80%
Short Ratio (days to cover)	8.78

Income Statement

In the last 12 months, XERS had revenue of $246.03 million and -$32.00 million in losses. Loss per share was -$0.21.

Revenue	246.03M
Gross Profit	202.33M
Operating Income	-3.72M
Pretax Income	-59.08M
Net Income	-32.00M
EBITDA	8.37M
EBIT	-3.72M
Loss Per Share	-$0.21

Balance Sheet

The company has $59.29 million in cash and $257.22 million in debt, giving a net cash position of -$197.94 million or -$1.24 per share.

Cash & Cash Equivalents	59.29M
Total Debt	257.22M
Net Cash	-197.94M
Net Cash Per Share	-$1.24
Equity (Book Value)	-19.30M
Book Value Per Share	-0.12
Working Capital	90.41M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 82.24%, with operating and profit margins of -1.51% and -13.01%.

Gross Margin	82.24%
Operating Margin	-1.51%
Pretax Margin	-14.36%
Profit Margin	-13.01%
EBITDA Margin	3.40%
EBIT Margin	-1.51%
FCF Margin	n/a

Dividends & Yields

XERS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.03%
Shareholder Yield	-8.03%
Earnings Yield	-3.03%
FCF Yield	n/a

Analyst Forecast

The average price target for XERS is $6.25, which is -5.30% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$6.25
Price Target Difference	-5.30%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	19.64%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2